Hartsdale, NY, United States of America

Simon Hoffenberg

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Hartsdale, NY (US) (2013 - 2020)
  • Carmel, NY (US) (2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Simon Hoffenberg

Introduction

Simon Hoffenberg is a notable inventor based in Hartsdale, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of lysin polypeptides aimed at combating Gram-negative bacterial infections. With a total of seven patents to his name, Hoffenberg's work is at the forefront of medical innovation.

Latest Patents

Hoffenberg's latest patents focus on lysin polypeptides that are active against Gram-negative bacteria. The present disclosure provides methods and compositions that are useful for the prophylactic and therapeutic amelioration and treatment of infections caused by these bacteria. Furthermore, the disclosure outlines compositions and methods for incorporating and utilizing lysin polypeptides to enhance the efficacy of antibiotics that are generally suitable for treating Gram-negative bacterial infections.

Career Highlights

Throughout his career, Hoffenberg has worked with prominent organizations such as the International Aids Vaccine Initiative and Contrafect Corporation. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of infectious diseases.

Collaborations

Some of Hoffenberg's notable coworkers include Christopher Lee Parks and Raymond Schuch. Their collaborative efforts have further advanced the research and applications of lysin polypeptides in medical science.

Conclusion

Simon Hoffenberg's innovative work in the field of biotechnology, particularly with lysin polypeptides, showcases his commitment to improving healthcare solutions. His contributions are vital in the ongoing battle against antibiotic-resistant bacteria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…